These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20410163)

  • 21. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
    Park MK; Smith PC; Wanserski G; Neher JO
    Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acetylsalicylic acid does not prevent cardiovascular disease. Poor scientific support for therapeutic guidelines according to primary prevention studies].
    Mooe T
    Lakartidningen; 2006 Sep 20-26; 103(38):2732-6. PubMed ID: 17058766
    [No Abstract]   [Full Text] [Related]  

  • 23. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin for prevention of cancer and cardiovascular disease.
    Rose PW; Watson EK; Jenkins LS
    Br J Gen Pract; 2011 Jun; 61(587):412-5. PubMed ID: 21801534
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacological prevention of cardiovascular diseases in general practice].
    Meland E; Ellekjaer H; Gjelsvik B; Kimsås A; Holmen J; Hetlevik I
    Tidsskr Nor Laegeforen; 2000 Sep; 120(22):2643-7. PubMed ID: 11077509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.
    Hennekens CH; Sechenova O; Hollar D; Serebruany VL
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):170-6. PubMed ID: 17056829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin. New uses for an old standby.
    Mayo Clin Health Lett; 2002 Dec; 20(12):7. PubMed ID: 12526110
    [No Abstract]   [Full Text] [Related]  

  • 28. Aspirin for primary prevention of cardiovascular disease in women: does sex matter?
    Hung J
    Med J Aust; 2006 Mar; 184(6):260-1. PubMed ID: 16548826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
    Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
    Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis.
    Pignone M; Earnshaw S; Pletcher MJ; Tice JA
    Arch Intern Med; 2007 Feb; 167(3):290-5. PubMed ID: 17296886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-examining the cardiovascular therapeutic benefits of aspirin.
    Finks SW
    South Med J; 2008 Jul; 101(7):679-80. PubMed ID: 18580736
    [No Abstract]   [Full Text] [Related]  

  • 32. First-generation agents: aspirin, heparin and coumarins.
    Mueller RL
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):23-53. PubMed ID: 15171956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
    Rodondi N; Bauer DC
    Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
    [No Abstract]   [Full Text] [Related]  

  • 34. [Aspirin for primary prevention of asymptomatic atherosclerosis].
    Lévesque H
    J Mal Vasc; 2002 Dec; 27(5):263-6. PubMed ID: 12525771
    [No Abstract]   [Full Text] [Related]  

  • 35. Gender differences in the primary prevention of stroke with aspirin.
    Adelman EE; Lisabeth L; Brown DL
    Womens Health (Lond); 2011 May; 7(3):341-52; quiz 352-3. PubMed ID: 21612354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin for the primary prevention of cardiovascular events.
    McLaughlin GE
    Ann Intern Med; 2002 Oct; 137(7):622-3. PubMed ID: 12353960
    [No Abstract]   [Full Text] [Related]  

  • 37. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
    Zhang C; Sun A; Zhang P; Wu C; Zhang S; Fu M; Wang K; Zou Y; Ge J
    Diabetes Res Clin Pract; 2010 Feb; 87(2):211-8. PubMed ID: 19853947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Uncertain benefit of low dosage ASA in peripheral arterial disease. Low dosage in symptomatic--individual assessment in asymptomatic disease].
    Norgren L; Bergqvist D; Pärsson H
    Lakartidningen; 2010 Jun; 107(23):1534-5. PubMed ID: 20617774
    [No Abstract]   [Full Text] [Related]  

  • 39. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
    Olson J; Huntington J
    J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspirin for the prevention of cardiovascular morbidity.
    Sanchez-Ross M; Waller AH; Maher J; Klapholz M; Haider B; Kaluski E
    Minerva Med; 2010 Aug; 101(4):205-14. PubMed ID: 21030934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.